Johnson & Johnson (JNJ) debt: $41.4B
Johnson & Johnson had $41.4B of long-term debt on Dec 28, 2025, including the part due within a year, up 27.9% from $32.4B a year earlier.
From Johnson & Johnson's filings with the SEC · Read the filing · JNJ stock page
Johnson & Johnson debt by year
#36 of 2,129 US companies by debt · See the full ranking
| Year ended | Debt | Change |
|---|---|---|
| Dec 28, 2025 | $41.4B | +28% |
| Dec 29, 2024 | $32.4B | +18% |
| Dec 31, 2023 | $27.4B | -4% |
| Jan 1, 2023 | $28.4B | -11% |
| Jan 2, 2022 | $32.1B | – |
Debt of similar companies
Companies in the same industry as Johnson & Johnson, by SEC industry code, with the closest debt. Each name opens the same page for that company.
| Company | Debt, latest year | Year ended |
|---|---|---|
| Pfizer | $64.6B | Dec 31, 2025 |
| AbbVie | $64.5B | Dec 31, 2025 |
| Merck | $49B | Dec 31, 2025 |
| Bristol Myers Squibb | $44.8B | Dec 31, 2025 |
| Johnson & Johnson | $41.4B | Dec 28, 2025 |
| Eli Lilly | $40.9B | Dec 31, 2025 |
| Bausch Health Companies | $20.8B | Dec 31, 2025 |
Questions and answers
What is Johnson & Johnson's debt?
Johnson & Johnson had $41.4B of long-term debt on Dec 28, 2025, including the part due within a year, up 27.9% from $32.4B a year earlier.
Numbers as reported in Johnson & Johnson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology